HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Citius Pharmaceuticals, Inc. (CTXR)
1.22  0.12  (10.91%) 07-03 16:37
Open: 1.1 High: 1.23
Pre.close: 1.1 Low: 1.08
Volume: 2,200,916 Ave vol: 2,921,417
52w High: 1.97 52w Low: 0.4
MA(50): 0.945 MA(200): 0.861
EPS: -0.623 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.citiuspharma.com
Market Cap (M): 55
Shares Out (M): 45
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bullish
Target 1: 1.79 Target 2: 2.30
Resist 1: 1.53 Resist 2: 1.97
Support 1: 0.82 Support 2: 0.68
Company key metrics
Revenue per Share: 0
Net Income per Share: -0.7739
Cash per Share: 0.5671
Book Value per Share: 1.7202
Price to Sales: 0
Price to Book Value: 0.8894
Earnings Yield: -0.5058
Dividend Yield: 0
Debt to Equity: 0.1143
Debt to Assets: 0.1026
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Neutral
Price to Earnings: Neutral
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 30 Jun 2020
Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% - Yahoo Finance

Fri, 26 Jun 2020
Stock Breakout: Shares Of Citius Pharmaceuticals, Inc. (CTXR) Spike On New Interest - Invest Million

Mon, 22 Jun 2020
Citius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor Forum - PRNewswire

Tue, 30 Jun 2020
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At Life Sciences Investors Forum - BP Journal

Tue, 30 Jun 2020
Citius Pharmaceuticals Inc (CTXR) Stock: What's Next? - InvestorsObserver

Wed, 10 Jun 2020
Is Citius Pharmaceuticals, Inc. (CTXR) a good SWING-TRADE Candidate? - The News Heater

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.